CLC Number:
[1] Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127(20): 2391-2405. [2] Vannucchi AM, Masala G, Antonioli E, et al. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms[J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(7): 2068-2073. [3] Marchetti M, Carobbio A, Capitoni E, et al. Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: a systematic review[J]. Am J Hematol, 2018, 93(5): 698-703. [4] Holst JM, Plesner TL, Pedersen MB, et al. Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort[J]. Haematologica, 2020, 105(10): 2432-2439. [5] Cheon HJ, Dziewulska KH, Moosic KB, et al. Advances in the diagnosis and treatment of large granular lymphocytic leukemia[J]. Curr Hematol Malig Rep, 2020, 15(2): 103-112. [6] Koskela HL, Eldfors S, Ellonen P, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia[J]. N Engl J Med, 2012, 366(20): 1905-1913. [7] Kennedy JA, Medeiros JJF, Dobson SM, et al. Distinct patterns of clonal evolution in patients with concurrent myelo- and lymphoproliferative neoplasms[J]. Blood, 2018, 132(20): 2201-2205. [8] Dong QZ, Xiu Y, Bossler A, et al. CLL dedifferentiation to clonally related myeloid cells[J]. Blood Adv, 2020, 4(24): 6169-6174. [9] Porpaczy E, Tripolt S, Hoelbl-Kovacic A, et al. Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy[J]. Blood, 2018, 132(7): 694-706. [10] Rumi E, Baratè C, Benevolo G, et al. Myeloproliferative and lymphoproliferative disorders: State of the art[J]. Hematol Oncol, 2020, 38(2): 121-128. [11] Mouchel PL, Syrykh C, Laurent C, et al. First case of classical Hodgkin-like EBV-positive lymphoproliferative disorder under ruxolitinib therapy[J]. Am J Hemato, 2021, 96(6): 755-756. [12] Pemmaraju N, Kantarjian H, Nastoupil L, et al. Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy[J]. Blood, 2019, 133(21): 2348-2351. [13] Wang J C, Kundra A, Andrei M, et al. Myeloid-derived suppressor cells in patients with myeloproliferative neoplasm[J]. Leuk Res, 2016, 43: 39-43. doi: 10.1016/j.leukres.2016.02.004. [14] Dumitriu B, Ito S, Feng X, et al. Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study[J]. Lancet Haematol, 2016, 3(1): e22-e29. [15] Tefferi A. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management[J]. Am J Hematol, 2021, 96(1): 145-162. |
[1] | ZHOU Lanlan, PAN Xueyi, GUO Yu. Clinical characteristics and prognosis of 48 patients with mixed phenotype acute leukemia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 79-83. |
[2] | YANG Juan, QIU Zongjian, SONG Qiang. Impacts of Simvastatin on DNA methyltransferase of cell line NB4 in acute myeloid leukemia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 28-32. |
[3] | QIU Zongjian, YANG Juan, SONG Qiang. Role of decitabine in the mitochondria biogenesis of synchronized G0/G1 phase MDS-L cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 5-9. |
[4] | ZHAI Shan-shan1, DING Bu-tong2, LI Hai-xia3, CHEN Yun1, CHANG Ya-li1, SANG Tan1, GUO Nong-jian1. Differential expressions of microRNAs in the CD138+ cells of multiple myeloma patients with deletion of chromosome 13 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 80-84. |
[5] | SUN Yuan-xin1, QIN Xue-mei1, LIU Xi-min2, WANG Li-zhi2, LIU Chuan-fang1, LIU Lu1. Relationship between regulatory T cells, IL-35 and aGVHD after allo-HSCT [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 89-94. |
[6] | XU Jia, SONG Qiang. Deletion of the RASSF1A gene and promoter methylation in the bone marrow of patients with myelodysplastic syndromes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 65-69. |
[7] |
SANG Tan1, DING Bu-tong2, CHANG Ya-li1, CHEN Yun1, LI Zhi-hong2,WANG Yun-shan2, HAN Shu-yi2, TONG Shu-qing2, GUO Nong-jian1 .
ETV6 gene rearrangements in adult acute lymphoblastic leukemia and their clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 79-82. |
[8] |
YIN Dong-mei1, XU Hong-zhi1, ZHANG Jing-yao1, SUI Xiao-hui1, CUI Bin2, MA Chun-yan2, ZHEN Chang-qing1.
Changes and clinical significances of CD4+T cell subsets in aplastic anemia, myelodysplastic syndromes and acute myeloid leukemia patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 66-70. |
[9] | WANG Rui-jie1, XU Hong-zhi1, HUANG Min3, MA Chun-yan2, SUI Xiao-hui1, LIU Xin1, ZHANG Bing-chang3, LI Yuan-tang3. Cell cycle distributions and cell proliferation-related protein expression in myelodysplastic syndromes, aplastic anemia, and acute leukemia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(2): 97-101. |
[10] | ZHOU Liyun, SONG Qiang, LI Lizhen, ZHAO Chuanli, WANG Luqun. Expression and function of the FLT3 gene in patients with myelodysplastic syndromes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(4): 91-. |
[11] | SUN Pei1,2, GAO Qingzhen2, REN Wanjun2, ZHANG Ruibin2, WANG Xiaoping2, LIU Zidong2. Distribution features of chimerism induction of allogeneic bone marrow cells in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(1): 38-. |
[12] |
.
Deletion of the p15 Gene and Promoter Methylation in the Bone Marrow of patients with Myelodysplastic Syndromes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(10): 106-109. |
[13] |
ZHAO Guangling1, XU Hongzhi1, HUANG Min1, LI Yuantang2, WU Huanling2, LI Jianfeng3, MA Chunyan3 . Immunophenotyping in myelodysplastic syndrome and aplastic anemia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(02): 53-57. |
[14] | JIN Hong,CONG Ya-qin,HU Xiao-jing,JIANG Yu-jie. The D-loop region of mitochondrial DNA in myelodysplastic syndromes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(5): 453-456. |
[15] | DOU Chunhui, SHAO Jianhua, DONG Xuebin, ZHANG Ling, CHEN Ping, ZHAO Hongyu, GU Linping, SUN Lin, XIE Jie, WANG Min, WANG Juan, LI Na, LI Fan, LI Daqi. Effect of gene mutation on the clinical efficacy of decitabine for patients with myelodysplastic syndrome [J]. Journal of Shandong University (Health Sciences), 2019, 57(3): 42-48. |
|